In critically ill patients, the use of a balanced crystalloid rather than saline may lead to a reduction in the composite outcome measure, MAKE-30. Level of evidence: 2b (randomised controlled trial (RCT) with a high risk of bias) 
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Three-part clinical question:
Patients: All adult patients admitted to one of five intensive care units (ICUs) at a single academic centre in the United States. Intervention: Each of the five ICUs were assigned to use either balanced crystalloid solution (either lactated Ringer's solution or Plasma-lyte A) or 0.9% saline for each month of participation in the trial. All adult patients being admitted to each of the ICUs, therefore received whichever intravenous fluid that particular unit had been assigned. ICUs were randomised to use saline during even numbered months and balanced crystalloid during odd numbered months or vice versa. Outcomes: The primary outcome was the proportion of patients who met one or more criteria for a Major Adverse Kidney Event at 30 days (MAKE30): Mortality, new receipt of renal replacement therapy (RRT) or persistent renal dysfunction (defined as a final inpatient creatinine value 5200% of the baseline value). Censored at hospital discharge or 30 days post-enrolment, whichever occurred first. Secondary outcomes were split into clinical and renal outcomes. Secondary clinical outcomes included in-hospital death before ICU discharge or at 30 days or 60 days, ICU-free days, ventilator-free days, vasopressor-free days and days alive and free of RRT during the 28 days after enrolment. Secondary renal outcomes included new receipt of RRT, persistent renal dysfunction and the development of a stage 2 or higher acute kidney injury (AKI).
Study design:
Pragmatic, single centre, un-blinded, cluster-randomised, multiple cross-over trial with intention-totreat analysis.
Study patients:
Inclusion criteria: All adult patients admitted to one of five ICUs (medical, neurological, cardiac, trauma and surgical) at a single academic centre in the U.S. (Vanderbilt Medical Centre, Nashville, Tennessee) over a 22-month period. Exclusion criteria: Patients aged under 18 years of age. Study groups: ICUs admitting primarily from the emergency department (ED) were allocated the same fluid at the same time to ensure fluid administered in the ED was likely to be the same as that given in the ICU. In contrast, ICUs admitting patients from theatre areas were assigned to the alternative crystalloid solution. Fluids administered in theatres were then matched with those allocated to the post-surgical ICU for that particular month. In total, 15,802 patients were assigned to receive either balanced crystalloid or saline; 7942 patients received balanced crystalloid whilst 7860 patients received saline. A sample size of 14,000 patients was adjusted from an initial number of 8000 patients following analysis of observational data, obtained during the preceding year, indicating the incidence of the outcome in the saline group would be 15%. 1 This would provide a power of 90% to detect and absolute difference of 1.9 percentage points between the two groups with a type-1 error rate of 0.05.
Results:
The published results would tend to suggest that the use of balanced crystalloid solution, as opposed to saline, in critically ill patients resulted in an absolute difference of 1.1 percentage points in favour of using balanced crystalloid in the primary outcome (see table 1 ).
However, these results were generated using adjusted variables. Using CATmaker TM software to analyse the published raw results suggests that the 95% CIs for RRR, ARR and therefore NNT include zero indicating a non-significant statistical result (see table 2 ). CATmaker TM analysis of the individual components of the composite outcome confirms that none of them reach statistical significance independently (Table 3) .
For secondary outcomes, there was no significant difference in the number of ICU-free days, ventilator free days or the incidence of stage 2 or higher AKI. There was a significantly lower incidence of hyperchloraemia (chloride >110 mmol/l) or low serum bicarbonate (<20 mmol/l) in the balanced group. No. There are no specific indications to audit practice based on the findings of this study.
